Sodium-glucose transporter-2 inhibition as an antidiabetic therapy

被引：20
|
作者：
Ferrannini, Ele [1 ]
机构：
[1] Univ Pisa, Dept Internal Med, Pisa, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2010年 / 25卷 / 07期
关键词：
diabetes mellitus; glycosuria; SGLT-2; inhibitors; sodium-glucose transporters; INSULIN; DAPAGLIFLOZIN; RATS;
D O I：
10.1093/ndt/gfq249
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：2041 / 2043
页数：3
相关论文
共 50 条
  • [1] Sympathomodulatory effects of sodium-glucose transporter-2 inhibitors in the kidneys and beyond
    Blankestijn, Peter J.
    Wanner, Christoph
    Grassi, Guido
    JOURNAL OF HYPERTENSION, 2017, 35 (10) : 1966 - 1967
  • [2] Sodium-glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering?
    Gilbert, Richard E.
    KIDNEY INTERNATIONAL, 2014, 86 (04) : 693 - 700
  • [3] Regional Distribution of Cardiologists and Prescription Patterns of Sodium-Glucose Transporter-2 Inhibitors in Japan
    Inoue, Daisuke
    Nishi, Hiroshi
    Inoue, Reiko
    Nangaku, Masaomi
    INTERNATIONAL HEART JOURNAL, 2021, 62 (03) : 592 - 600
  • [4] Recent progress of sodium-glucose transporter 2 inhibitors as potential antidiabetic agents
    Zhang, Yajing
    Ban, Huazhuo
    Yu, Runan
    Wang, Zhijian
    Zhang, Dayong
    FUTURE MEDICINAL CHEMISTRY, 2018, 10 (10) : 1261 - 1276
  • [5] Sodium-glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes
    Giugliano, Dario
    Longo, Miriam
    Scappaticcio, Lorenzo
    Caruso, Paola
    Esposito, Katherine
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [6] Safety and efficacy of sodium-glucose transporter-2 inhibitors in kidney transplant recipients: preliminary results
    Skalioti, Chrysanthi
    Tsiakas, Stathis
    Smyrli, Maria
    Tsoutsoura, Paraskevi
    Boletis, Ioannis
    Marinaki, Smaragdi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [7] Safety and efficacy of sodium-glucose transporter-2 inhibitors in kidney transplant recipients: preliminary results
    Skalioti, Chrysanthi
    Tsiakas, Stathis
    Smyrli, Maria
    Tsoutsoura, Paraskevi
    Boletis, Ioannis
    Marinaki, Smaragdi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2696 - I2696
  • [8] Sodium-glucose linked transporter 2 inhibitors in liver cirrhosis: Beyond their antidiabetic use
    Siafarikas, Christos
    Kapelios, Chris J.
    Papatheodoridi, Margarita
    Vlachogiannakos, John
    Tentolouris, Nikolaos
    Papatheodoridis, George
    LIVER INTERNATIONAL, 2024, 44 (04) : 884 - 893
  • [9] Sodium-glucose co-transporter 2 inhibition: the saga continues
    Crea, Filippo
    EUROPEAN HEART JOURNAL, 2022, 43 (41) : 4215 - 4218
  • [10] Pharmacoeconomic evaluation of sodium-glucose transporter-2 (SGLT2) inhibitors for the treatment of type 2 diabetes
    Rahman, Wedad
    Solinsky, Paul Joseph
    Munir, Kashif M.
    Lamos, Elizabeth M.
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (02) : 151 - 161
12345